Clinical Trials Browser

Ovarian Neoplasms × disitamab vedotin × Clear all

NCT06003231 2026-03-16

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

Phase 2 Active not recruiting

GynecologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT06540729 2025-07-08

DAB

Phase 2 Recruiting

Ovarian Neoplasms